Literature DB >> 30321934

Flexor hallucis longus tendon transfer for chronic Achilles tendon rupture. A retrospective study.

Ole Kristian Alhaug1, Gøran Berdal2, Elisabeth Ellingsen Husebye2, Kjetil Hvaal2.   

Abstract

BACKGROUND: The transfer of Flexor Hallucis Longus Tendon (FHL) is an established method for the treatment of chronic Achilles tendon ruptures. An extensive examination of power, strength, endurance and complications related to this procedure is presented.
METHODS: 21 patients treated with open FHL transfer for chronic Achilles tendon rupture were studied retrospectively. Medical records were reviewed. The patients were examined with a test battery for triceps surae strength, functional tests and PROMs.
RESULTS: The median maximal concentric strength was equal,1300 vs 1336W, comparing affected with unaffected side. The endurance tests showed a larger difference, 219J vs. 2398J, respectively. The median AOFAS score was 87. 11 of 21 patients sustained one or more complications; the most common were infection, disturbed wound healing, and clawing of small toes.
CONCLUSIONS: Patients achieve almost normal maximal strength after open FHL transfer, but endurance is notably lower. The complication rate was high.
Copyright © 2018 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic Achilles rupture; Complications; FHL tendon transfer; Functional outcome

Mesh:

Year:  2018        PMID: 30321934     DOI: 10.1016/j.fas.2018.07.002

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  2 in total

1.  Secondary reconstruction of chronic Achilles tendon rupture: flexor hallucis longus transfer versus plantaris longus augmentation.

Authors:  Sebastian Fischer; Rahel Kutscher; Yves Gramlich; Alexander Klug; Reinhard Hoffmann; Sebastian Manegold
Journal:  Int Orthop       Date:  2021-07-16       Impact factor: 3.075

Review 2.  Management of chronic Achilles ruptures: a scoping review.

Authors:  Zaki Arshad; Edward Jun Shing Lau; Shu Hui Leow; Maneesh Bhatia
Journal:  Int Orthop       Date:  2021-06-05       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.